# 159900

DYSTONIA 11, MYOCLONIC; DYT11


Alternative titles; symbols

MYOCLONUS-DYSTONIA SYNDROME
MYOCLONIC DYSTONIA
DYSTONIA, ALCOHOL-RESPONSIVE
MYOCLONUS, HEREDITARY ESSENTIAL


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
7q21.3 Dystonia-11, myoclonic 159900 AD 3 SGCE 604149
Clinical Synopsis
 
Phenotypic Series
 

INHERITANCE
- Autosomal dominant
HEAD & NECK
Neck
- Torticollis
NEUROLOGIC
Central Nervous System
- Myoclonus, axial (predominantly in upper limbs, occurs at rest and increases with activity or changes in posture)
- Subcortical origin of the myoclonus based on neurophysiologic studies
- Dystonia (may spontaneously remit in childhood or adolescence)
- Hypotonia (rare)
- Tremor
- Writer's cramp
Behavioral Psychiatric Manifestations
- Depression
- Anxiety
- Obsessive-compulsive disorder
- Panic attacks
- Agoraphobia
MISCELLANEOUS
- Onset in childhood or adolescence (mean age of 6 years, range 1 to 18)
- Variable pattern of body involvement although symptoms may predominate in upper or lower body
- Symptoms are often responsive to alcohol
- Maternal imprinting of SGCE results in reduced penetrance of the disorder when the mutation is inherited from the mother
MOLECULAR BASIS
- Caused by mutation in the epsilon-sarcoglycan gene (SGCE, 604149.0001)
Dystonia - PS128100 - 37 Entries
Location Phenotype Inheritance Phenotype
mapping key
Phenotype
MIM number
Gene/Locus Gene/Locus
MIM number
1p36.32-p36.13 Dystonia 13, torsion AD 2 607671 DYT13 607671
1p35.3 Dystonia, childhood-onset, with optic atrophy and basal ganglia abnormalities AR 3 617282 MECR 608205
1p35.1 Dystonia 2, torsion, autosomal recessive AR 3 224500 HPCA 142622
1p34.2 GLUT1 deficiency syndrome 2, childhood onset AD 3 612126 SLC2A1 138140
1p34.2 Dystonia 9 AD 3 601042 SLC2A1 138140
2p22.2 Dystonia 33 AD, AR 3 619687 EIF2AK2 176871
2q14.3-q21.3 Dystonia 21 AD 2 614588 DYT21 614588
2q31 Paroxysmal nonkinesigenic dyskinesia 2 AD 2 611147 PNKD2 611147
2q31.2 Dystonia 16 AR 3 612067 PRKRA 603424
2q35 Paroxysmal nonkinesigenic dyskinesia 1 AD 3 118800 PNKD 609023
2q37.3 Dystonia 27 AR 3 616411 COL6A3 120250
3p13 ?Dystonia 35, childhood-onset AR 3 619921 SHQ1 613663
4q21.1 Dystonia 37, early-onset, with striatal lesions AR 3 620427 NUP54 607607
5q22.3 ?Dystonia 34, myoclonic AD 3 619724 KCNN2 605879
7q21.3 Dystonia-11, myoclonic AD 3 159900 SGCE 604149
8p11.21 Dystonia 6, torsion AD 3 602629 THAP1 609520
9q22.32 Dystonia 31 AR 3 619565 AOPEP 619600
9q34 Dystonia 23 AD 2 614860 DYT23 614860
9q34.11 Dystonia-1, torsion AD 3 128100 TOR1A 605204
11p14.3-p14.2 Dystonia 24 AD 3 615034 ANO3 610110
11q13.2 Episodic kinesigenic dyskinesia 3 AD 3 620245 TMEM151A 620108
11q23.3 ?Dystonia 32 AR 3 619637 VPS11 608549
14q22.2 Dystonia, DOPA-responsive AD, AR 3 128230 GCH1 600225
16p11.2 Episodic kinesigenic dyskinesia 1 AD 3 128200 PRRT2 614386
16q13-q22.1 Episodic kinesigenic dyskinesia 2 AD 2 611031 EKD2 611031
17q22 Dystonia 22, juvenile-onset AR 3 620453 TSPOAP1 610764
17q22 ?Dystonia 22, adult-onset AR 3 620456 TSPOAP1 610764
18p11 Dystonia-15, myoclonic AD 2 607488 DYT15 607488
18p Dystonia-7, torsion AD 2 602124 DYT7 602124
18p11.21 Dystonia 25 AD 3 615073 GNAL 139312
19p13.3 Dystonia 4, torsion, autosomal dominant AD 3 128101 TUBB4A 602662
19q13.12 Dystonia 28, childhood-onset AD 3 617284 KMT2B 606834
19q13.2 Dystonia-12 AD 3 128235 ATP1A3 182350
20p13 Dystonia 30 AD 3 619291 VPS16 608550
20p11.2-q13.12 Dystonia-17, primary torsion AR 2 612406 DYT17 612406
22q12.3 Dystonia 26, myoclonic AD 3 616398 KCTD17 616386
Xq13.1 Dystonia-Parkinsonism, X-linked XLR 3 314250 TAF1 313650

TEXT

A number sign (#) is used with this entry because of evidence that myoclonic dystonia-11 (DYT11) is caused by heterozygous mutation in the epsilon-sarcoglycan gene (SGCE; 604149) on chromosome 7q21.


Description

Myoclonus-dystonia is a genetically heterogeneous disorder characterized by myoclonic jerks affecting mostly proximal muscles. Dystonia, usually torticollis or writer's cramp, is observed in most patients, but occasionally can be the only symptom of the disorder. Onset of the disorder is usually in the first or second decade. Symptoms often respond to alcohol, and patients may also have psychiatric abnormalities (Valente et al., 2003; Schule et al., 2004).


Clinical Features

Myoclonic dystonia, or myoclonus-dystonia, has dystonia as the core feature, but tremor or rapid jerky movements resembling myoclonus may also be present. The age of onset, pattern of body involvement, presence of myoclonus, and response to alcohol are all variable. Essential myoclonus is a relatively mild condition starting in the first or second decade, and is inherited as an autosomal dominant trait with incomplete penetrance. Some patients with essential myoclonus also have dystonia, but there are usually no other neurologic symptoms, and there may be a dramatic response to alcohol (Nemeth, 2002).

In a family of French Canadian background, a father and 5 of his 9 children showed onset of myoclonus in the first or second decade and a benign course without seizures, dementia, or neurologic signs other than myoclonus (Mahloudji and Pikielny, 1967). Because of the uncertainty of the nature of the case, on the basis of which Friedreich in 1881 introduced the term paramyoclonus multiplex, these cases might best be called hereditary essential myoclonus.

Daube and Peters (1966) reported 2 families with hereditary essential myoclonus in each of which affected members occurred in at least 4 generations, with male-to-male transmission but some skipped generations. Symonds (1953) described nocturnal myoclonus in a man and 5 of his 6 children. Muller and Kupke (1990) interpreted the family reported by Mahloudji and Pikielny (1967) as an instance of what they termed myoclonic dystonia, i.e., the association of torsion dystonia with myoclonus (muscle jerks). They pointed to families with the same disorder reported by Benedek and Rakonitz (1940), Quinn et al. (1988), and Kurlan et al. (1988).

Unlike other forms of dystonia (e.g., 128100), myoclonic dystonia may be highly responsive to ethanol ingestion and frequently also to clonazepam therapy and usually pursues a benign course. Kyllerman et al. (1990) described a 6-generation Swedish family with alcohol-responsive hereditary myoclonus. After clinical examination of 20 affected persons, myoclonus was found in the arms, shoulders, and neck of 17. The onset of myoclonus was between 2 and 3 years of age. The onset of leg dystonia was from 6 to 18 months of age.

Nygaard et al. (1999) reported a large American kindred of European and Native American ancestry with essential familial myoclonic dystonia that was responsive to alcohol. There were 10 definitely affected living individuals. Four had both myoclonus and dystonia, 5 had myoclonus alone, and 1 had brachial dystonia only. However, among the 5 judged to have only myoclonus, 4 had occasional sustained contractions and subtle posturing that might suggest mild dystonia. Mean age at onset of symptoms was 6.5 years (range, 4 to 15 years) in the 8 individuals able to recall onset. All affected individuals who tried alcohol reported relief of symptoms. Several family members had sought medical attention; levodopa was ineffective, and clonazepam or valproate gave mild benefit. Nine out of the 10 affected family members reported psychiatric problems, including diagnoses and treatment for depression, anxiety, and obsessive-compulsive disorder.

Asmus et al. (2002) reported 24 affected patients from 9 families, confirmed by genetic analysis of the SGCE gene (1 previously known and 6 novel heterozygous mutations were identified). The clinical presentation was homogeneous, with myoclonus affecting primarily the neck, trunk, and upper extremities at a mean age of onset of 5.4 years (range 0.5 to 20 years). Dystonia presented mostly in a focal distribution as cervical dystonia and/or writer's cramp at a mean age of onset of 8.8 years (range 1 to 38 years), often occurring in parallel with worsening of myoclonus. Myoclonus was improved by alcohol in 21 of 24 affected, and 5 affected members of 3 families had a history of panic attacks, depression, and agoraphobia. Pedigree analysis showed reduced penetrance of the phenotype upon maternal inheritance of the mutated allele, indicating genomic imprinting.

Doheny et al. (2002) described in detail the motor symptoms, psychiatric disorders, and neuropsychologic deficits in 3 families with myoclonus-dystonia syndrome who carried mutations in the SGCE gene. One family also carried a mutation in the DRD2 gene. Motor expression was variable, with onset of myoclonus or dystonia or both affecting the upper body and progression to myoclonus and dystonia in most cases. Psychiatric profiles revealed depression, obsessive-compulsive disorder, substance abuse, anxiety/panic/phobic disorders, and psychosis in 2 families, and depression only in the third family. Averaged scores from cognitive testing showed impaired verbal learning and memory in 1 family, impaired memory in the second family, and no cognitive deficits in the third family. Doheny et al. (2002) concluded that cognitive deficits may be associated with myoclonus-dystonia and that psychiatric abnormalities correlated with motor symptoms in affected individuals.

In a large family with myoclonus-dystonia syndrome and a mutation in the SGCE gene (604149.0008), Hjermind et al. (2003) reported prominent involvement of the legs, leading to disability in some, and laryngeal involvement causing vocal myoclonus.

Valente et al. (2005) identified SGCE mutations in 6 (21%) of 29 patients with essential myoclonus and myoclonic dystonia; no SGCE mutations were identified in another 29 patients with a broader myoclonus/dystonia phenotype. The patients with mutations typically had early onset of predominant myoclonus and milder dystonia, with an upper body predilection. Dystonia tended to have a later onset than that of myoclonus. Most patients' symptoms improved with alcohol. Autosomal dominant paternal inheritance was observed. Valente et al. (2005) noted the clinical phenotypic overlap of myoclonic dystonia, essential myoclonus, 'jerky' dystonia, Ramsay Hunt syndrome (213400), and benign hereditary chorea (118700).

Gerrits et al. (2006) reported 31 unrelated patients with a clinical diagnosis of myoclonus-dystonia, of whom 7 were found to have mutations in the SGCE gene. Clinical comparisons between mutation-positive and mutation-negative patients showed that the former had earlier disease onset before age 20 years. Mutation carriers first presented mostly with both myoclonus and dystonia, whereas mutation-negative patients usually presented with one or the other symptom. Those with mutations also tended to have a family history of the disorder, as well as truncal myoclonus and axial dystonia. There were no significant differences between the 2 groups regarding alcohol sensitivity or psychiatric symptoms.

Roze et al. (2008) reviewed the features of 41 patients from 22 French families with SGCE mutation-positive myoclonus dystonia. The mean age at onset was 6 years (range, 1 to 18 years). Myoclonus was the presenting feature in 29 patients, 5 of whom also presented with dystonia. Ten patients presented with isolated dystonia, and 2 patients from the same family presented with hypotonia. Dystonia was axial, mostly cervical, in 13 patients, in the upper limbs in 18 patients, and in the lower limbs in 9 patients. One patient had laryngeal dystonia. Myoclonus involved the axis in 90% of cases, most commonly with cervical and upper limb involvement. Myoclonus of the face and voice occurred in 27% and 24%, respectively, and involved the lower limbs in 34% of patients. Myoclonus was present at rest in 70% of patients, and increased with posture and action in 95%. Neurophysiologic studies showed that myoclonus could be synchronous or asynchronous, isolated, and mostly arrhythmic. The studies indicated a subcortical origin: myoclonus was stimulus insensitive; the mean duration of myoclonus was 95 seconds, which is longer than that observed in cortical myoclonus; and there were no features of cortical hyperexcitability, as reflected by a negative C-reflex response. Nine patients had spontaneous remission of the dystonia during childhood or adolescence. Eight patients had associated psychiatric disturbances, including obsessive-compulsive disorder, severe anxiety and depression, attention-deficit hyperactivity disorder, and phobic disorder. There were no clear genotype/phenotype correlations.


Other Features

Hess et al. (2007) studied psychiatric manifestations in 5 unrelated families with myoclonus-dystonia confirmed by genetic analysis. Among a total of 64 family members, manifesting SGCE mutation carriers showed increased alcohol dependence compared to nonmanifesting carriers and controls (35% and 11.4%, respectively), but the association was not significant for the mutation carrier group overall. There was an increase in the rate of obsessive-compulsive disorder (OCD) in mutation carriers compared to non-carriers (16.7% and 3.0%, respectively), but it did not reach significance. However, there was no case of OCD among 10 nonmanifesting carriers, and only 1 noncarrier fit OCD criteria. In patients with OCD, the onset of motor symptoms preceded OCD by about 10 years. Hess et al. (2007) concluded that alcohol dependence in myoclonus-dystonia patients is related to self-medication to improve motor symptoms, whereas OCD may be a manifestation of mutant gene expression triggered after the onset of movement symptoms.


Clinical Management

Azoulay-Zyss et al. (2011) reported favorable results in 5 patients with severe and refractory myoclonus-dystonia treated with bilateral deep brain stimulation of the internal pallidum. All patients showed significant functional improvement and improvement on measurable scoring systems at 6 to 9 months after surgery. The median improvement in score was an 85% decrease for dystonia and an 83% decrease for myoclonus. After 15 to 18 months, 3 patients were medication-free, 1 of whom received botulism injections for mild cervical dystonia. The other 2 patients were on low doses of benzodiazepines. There were no adverse effects.

Contarino et al. (2011) reported a significantly favorable motor response in 5 patients with myoclonus-dystonia after deep brain stimulation of the internal pallidum. However, 4 of 5 patients had worsening of preexisting psychiatric disorders after the treatment despite the improvement of the motor disabilities. One patient had no change in the psychiatric comorbidity. Preoperative psychiatric symptoms were present in all 5 patients, and mainly included depressive episodes and social anxiety disorder, but were untreated and not considered severe enough to contraindicate surgery. Contarino et al. (2011) concluded that psychiatric comorbidity may be intrinsic to the disorder or secondary to the movement disorder, but that worsening could not be definitively linked to the treatment. They recommended that pre- and postoperative psychiatric evaluation needs to be considered in all patients with this disorder. Grabli et al. (2011) noted that of the 5 patients in their study (Azoulay-Zyss et al., 2011), all had mild generalized anxiety and 1 had a major depressive episode before the treatment. No clinically meaningful psychiatric adverse effect was identified during 18-month follow-up of these patients, and some patients reported improvement in their anxiety. The discrepancy in the outcome between the 2 studies could not be explained.


Mapping

In the Swedish family reported by Kyllerman et al. (1990), Wahlstrom et al. (1994) excluded linkage of the gene responsible for this disorder to 9q32-q34, where the DYT1 gene (TOR1A; 605204) for susceptibility to early-onset torsion dystonia (128100) was mapped, suggesting another locus was responsible. In a large German kindred with alcohol-responsive myoclonic dystonia, Gasser et al. (1996) also excluded linkage to the 9q34 region.

Linkage to Chromosome 7q21

Zimprich et al. (2001) performed pedigree analysis on all families with myoclonus-dystonia syndrome who had known mutations in SGCE (604149) and/or linkage to chromosome 7q21 (DYT11). The high level of dependence of penetrance on the parental origin of the disease allele was demonstrated. Of 62 clinically affected individuals (40 males and 22 females), 49 inherited the disease from their father and only 4 from their mother. In 9 cases, parental origin could not be determined. In contrast, they found a maternal origin of the affected allele in 14 of 18 clinically asymptomatic carriers (12 males and 6 females, carrier status being determined either by sequencing or by pedigree position), whereas paternal transmission occurred in only 3. In one case, parental origin could not be determined.

Nygaard et al. (1999) mapped the locus for myoclonic dystonia in the large American kindred of European and Native American ancestry studied by them to a 28-cM interval spanning the markers D7S802 and D7S1799 in 7q21-q31. The highest pairwise lod score was 3.91 at theta of 0.0 at both D7S657 and D7S796.

Klein et al. (2000) performed genetic studies in 8 families with myoclonic dystonia. In all 8 families, they found linkage to chromosome 7 markers, with a combined multipoint lod score of 11.71. Recombination events in the families placed the disease gene within a 14-cM interval flanked by D7S2212 and D7S821. These data provided evidence for a major locus for myoclonic dystonia on 7q21.

Asmus et al. (2001) narrowed the 7q21-q31 locus for the myoclonus-dystonia syndrome in German families.

Vidailhet et al. (2001) performed linkage analysis in 3 families with myoclonic dystonia and 1 family with essential myoclonus, and found positive lod scores for 6 markers on 7q21-q31 in all families. Linkage to the DRD2 locus was excluded in all families. Although there was wide clinical variation both between and within families in age of onset, involvement of limbs, trunk, or neck, and responsiveness to alcohol, the authors suggested that different phenotypes may be due to allelic mutations in a single gene.


Heterogeneity

Valente et al. (2003) excluded mutations in the SGCE gene in 16 patients with myoclonus dystonia, indicating genetic heterogeneity. Three patients had a family history consistent with autosomal dominant inheritance. Schule et al. (2004) also excluded SGCE mutation in 5 of 7 families with autosomal dominant myoclonus dystonia, again indicating genetic heterogeneity.

Orth et al. (2007) reported a 3-generation family with both myoclonus dystonia and Gilles de la Tourette syndrome (GTS; 137580). There were 11 affected individuals: 3 had myoclonus dystonia, 2 had dystonia, 1 had GTS, 1 had tics, and 4 had various combinations of these with obsessive compulsive disorder. The phenotype of those with myoclonus dystonia was similar to that described for most families, with predominantly head, neck and arm myoclonus, mild cervical dystonia, and writer's cramp. Linkage analysis excluded association to the SGCE, DYT15 (607488), DYT1, or DRD2 (126450) loci, and no pathogenic changes were identified in the SLITRK1 gene (609678). Orth et al. (2007) suggested that there may be a novel susceptibility gene for both myoclonus dystonia and Tourette syndrome.


Inheritance

The transmission pattern of myoclonic dystonia in the families reported by Zimprich et al. (2001) was consistent with autosomal dominant inheritance.


Molecular Genetics

Using a positional cloning approach, Zimprich et al. (2001) identified 5 different heterozygous loss-of-function mutations in the SGCE gene (604149.0001-604149.0005) in patients with myoclonus-dystonia syndrome. SGCE was found to be expressed in all brain regions examined. Pedigree analysis showed a marked difference in penetrance depending on the parental origin of the disease allele. This was indicative of a maternal imprinting mechanism, which had been demonstrated in the case of the mouse epsilon-sarcoglycan gene.

Using bisulfite genomic sequencing to study methylation patterns of the SGCE gene in samples from patients with myoclonus-dystonia syndrome, Grabowski et al. (2003) found strong evidence for maternal imprinting of the SGCE gene.

In a Dutch family with myoclonus-dystonia syndrome spanning 5 generations, previously reported by Doheny et al. (2002), Foncke et al. (2003) identified a mutation in the SGCE gene (604149.0007). In addition to the typical motor symptoms, 3 of 5 living affected members also had EEG abnormalities and seizures. Seizures consisted of episodes of reduced consciousness and staring, amnesia, and panic-like feelings, suggestive of temporal-limbic origin. Foncke et al. (2003) suggested that epilepsy should not be considered an exclusion criterion for the clinical diagnosis of myoclonus-dystonia syndrome.

Asmus et al. (2005) identified 2 different large heterozygous deletions in the SGCE gene (604149.0010 and 604149.0011) in affected members from 2 unrelated families with myoclonic dystonia. The deletion was paternally inherited in all cases with motor symptoms. In 1 family, a man who inherited the mutation maternally did not have motor symptoms but did have alcohol dependence.

Tezenas du Montcel et al. (2006) identified 13 different mutations in the SGCE gene in 16 of 76 unrelated French Caucasian patients with myoclonus-dystonia or essential myoclonus. In 12 families (75%), at least 1 other family member was affected. Penetrance was complete in paternal transmissions and null in maternal transmissions. None of the patients had severe psychiatric disorders.

In affected members of a large Dutch family with myoclonus-dystonia syndrome reported by Korten et al. (1974), Foncke et al. (2006) identified a heterozygous mutation in the SGCE gene (604149.0012). The mutation was identified in all 19 symptomatic relatives, all 5 'possibly affected' relatives, and in 9 clinically unaffected relatives. All symptomatic individuals inherited the mutation from their father, and all asymptomatic individuals inherited it from their mother. Foncke et al. (2006) noted that subtle distal myoclonus of the fingers was a prominent feature in this family.

Associations Pending Confirmation

In a family containing 8 members with myoclonic dystonia, Klein et al. (1999) found heterozygosity for a variation in the DRD2 gene (V154I; 126450.0001); however, Klein et al. (2002) later identified a 5-bp deletion in the SGCE gene (604149.0005) in all 8 affected members. There were 2 unaffected carriers of both mutations. The contribution of each mutation to the clinical phenotype could not be determined, but the phenotype most likely resulted from the SGCE mutation, as Klein et al. (2000) showed that the V154I DRD2 mutant protein was similar to wildtype and did not show impaired activity in in vitro studies. (See also Furukawa and Rajput, 2002).

By direct sequencing, Klein et al. (2000) excluded DRD2 mutations in 5 unrelated probands with myoclonus dystonia. Four additional families were excluded by linkage analysis. Durr et al. (2000) excluded mutations in the DRD2 gene in 9 unrelated families with myoclonic dystonia or essential myoclonus and variable responses to alcohol. The authors concluded that DRD2 mutations are rare in these disorders.

For discussion of a possible association between myoclonic dystonia and variation in the DYT1 (TOR1A) gene, see 605204.0002.


Cytogenetics

Guettard et al. (2008) reported a 35-year-old man with myoclonus-dystonia and Silver-Russell syndrome (SRS; 180860). Cytogenetic analysis identified mosaicism for a small supernumerary ring chromosome derived from the pericentric region of chromosome 7, which was considered unlikely to contribute to the phenotype as it contained only the EGFR gene (131550). Microsatellite analysis indicated loss of the paternal allele and maternal uniparental disomy of chromosome 7 (UPD7) that was maternally imprinted with loss of SGCE expression. There were no mutations in the SGCE gene. The findings indicated that UPD7 resulted in repression of both alleles of the maternally imprinted SGCE gene, suggesting loss of function of SGCE as the disease mechanism.


REFERENCES

  1. Asmus, F., Salih, F., Hjermind, L. E., Ostergaard, K., Munz, M., Kuhn, A. A., Dupont, E., Kupsch, A., Gasser, T. Myoclonus-dystonia due to genomic deletions in the epsilon-sarcoglycan gene. Ann. Neurol. 58: 792-797, 2005. [PubMed: 16240355, related citations] [Full Text]

  2. Asmus, F., Zimprich, A., Naumann, M., Berg, D., Bertram, M., Ceballos-Baumann, A., Pruszak-Seel, R., Kabus, C., Dichgans, M., Fuchs, S., Muller-Myhsok, B., Gasser, T. Inherited myoclonus-dystonia syndrome: narrowing the 7q21-q31 locus in German families. Ann. Neurol. 49: 121-124, 2001. [PubMed: 11198282, related citations] [Full Text]

  3. Asmus, F., Zimprich, A., Tezenas du Montcel, S., Kabus, C., Deuschl, G., Kupsch, A., Ziemann, U., Castro, M., Kuhn, A. A., Strom, T. M., Vidailhet, M., Bhatia, K. P., Durr, A., Wood, N. W., Brice, A., Gasser, T. Myoclonus-dystonia syndrome: epsilon-sarcoglycan mutations and phenotype. Ann. Neurol. 52: 489-492, 2002. [PubMed: 12325078, related citations] [Full Text]

  4. Azoulay-Zyss, J., Roze, E., Welter, M.-L., Navarro, S., Yelnik, J., Clot, F., Bardinet, E., Karachi, C., Dormont, D., Galanaud, D., Pidoux, B., Cornu, P., Vidailhet, M., Grabli, D. Bilateral deep brain stimulation of the pallidum for myoclonus-dystonia due to epsilon-sarcoglycan mutations: a pilot study. Arch. Neurol. 68: 94-98, 2011. [PubMed: 21220679, related citations] [Full Text]

  5. Benedek, L., Rakonitz, E. Heredopathic combination of a congenital deformity of the nose and of myoclonic torsion dystonia. J. Nerv. Ment. Dis. 91: 606-616, 1940.

  6. Biemond, A. Paramyoclonus multiplex (Friedreich). Clinical and genetic aspects. Psychiat. Neurol. Neurochir. 66: 270-276, 1963. [PubMed: 14062193, related citations]

  7. Contarino, M. F, Foncke, E. M., Cath, D. C., Schuurman, P. R., Speelman, J. D., Tijssen, M. A. J. Effect of pallidal deep brain stimulation on psychiatric symptoms in myoclonus-dystonia due to epsilon-sarcoglycan mutations. (Letter) Arch. Neurol. 68: 1087-1088, 2011. [PubMed: 21825253, related citations] [Full Text]

  8. Daube, J. R., Peters, H. A. Hereditary essential myoclonus. Arch. Neurol. 15: 587-594, 1966. [PubMed: 5925999, related citations] [Full Text]

  9. Doheny, D. O., Brin, M. F., Morrison, C. E., Smith, C. J., Walker, R. H., Abbasi, S., Muller, B., Garrels, J., Liu, L., de Carvalho Aguiar, P., Schilling, K., Kramer, P., and 9 others. Phenotypic features of myoclonus-dystonia in three kindreds. Neurology 59: 1187-1196, 2002. [PubMed: 12391346, related citations] [Full Text]

  10. Durr, A., Tassin, J., Vidailhet, M., Durif, F., Jedynak, P., Agid, Y., Brice, A. D2 dopamine receptor gene in myoclonic dystonia and essential myoclonus. Ann. Neurol. 48: 127-128, 2000. [PubMed: 10894231, related citations] [Full Text]

  11. Foncke, E. M. J., Gerrits, M. C. F., van Ruissen, F., Baas, F., Hedrich, K., Tijssen, C. C., Klein, C., Tijssen, M. A. J. Distal myoclonus and late onset in a large Dutch family with myoclonus-dystonia. Neurology 67: 1677-1680, 2006. [PubMed: 17101905, related citations] [Full Text]

  12. Foncke, E. M. J., Klein, C., Koelman, J. H. T. M., Kramer, P. L., Schilling, K., Muller, B., Garrels, J., de Carvalho Aguiar, P., Liu, L., de Froe, A., Speelman, J. D., Ozelius, L. J., Tijssen, M. A. J. Hereditary myoclonus-dystonia associated with epilepsy. Neurology 60: 1988-1990, 2003. [PubMed: 12821748, related citations] [Full Text]

  13. Furukawa, Y., Rajput, A. H. Inherited myoclonus-dystonia: how many causative genes and clinical phenotypes? Neurology 59: 1130-1131, 2002. [PubMed: 12391338, related citations] [Full Text]

  14. Gasser, T., Bereznai, B., Muller, B., Pruszak-Seel, R., Damrich, R., Deuschl, G., Oertel, W. H. Linkage studies in alcohol-responsive myoclonic dystonia. Mov. Disord. 11: 363-370, 1996. [PubMed: 8813214, related citations] [Full Text]

  15. Gerrits, M. C. F., Foncke, E. M. J., de Haan, R., Hedrich, K., van de Leemput, Y. L. C., Baas, F., Ozelius, L. J., Speelman, J. D., Klein, C., Tijssen, M. A. J. Phenotype-genotype correlation in Dutch patients with myoclonus-dystonia. Neurology 66: 759-761, 2006. Note: Erratum: Neurology 68: 879 only, 2007. [PubMed: 16534121, related citations] [Full Text]

  16. Grabli, D., Roze, E., Azoulay-Zyss, J., Vidailhet, M. Reply to Contarino et al. Arch. Neurol. 68: 1088 only, 2011.

  17. Grabowski, M., Zimprich, A., Lorenz-Depiereux, B., Kalscheuer, V., Asmus, F., Gasser, T., Meitinger, T., Strom, T. M. The epsilon-sarcoglycan gene (SGCE), mutated in myoclonus-dystonia syndrome, is maternally imprinted. Europ. J. Hum. Genet. 11: 138-144, 2003. [PubMed: 12634861, related citations] [Full Text]

  18. Guettard, E., Portnoi, M.-F., Lohmann-Hedrich, K., Keren, B., Rossignol, S., Winkler, S., El Kamel, I., Leu, S., Apartis, E., Vidailhet, M., Klein, C., Roze, E. Myoclonus-dystonia due to maternal uniparental disomy. Arch. Neurol. 65: 1380-1385, 2008. [PubMed: 18852357, related citations] [Full Text]

  19. Hess, C. W., Raymond, D., de Varvalho Aguiar, P., Frucht, S., Shriberg, J., Heiman, G. A., Kurlan, R., Klein, C., Bressman, S. B., Ozelius, L. J., Saunders-Pullman, R. Myoclonus-dystonia, obsessive-compulsive disorder, and alcohol dependence in SGCE mutation carriers. Neurology 68: 522-524, 2007. [PubMed: 17296918, related citations] [Full Text]

  20. Hjermind, L. E., Werdelin, L. M., Eiberg, H., Krag-Olsen, B., Dupont, E., Sorensen, S. A. A novel mutation in the epsilon-sarcoglycan gene causing myoclonus-dystonia syndrome. Neurology 60: 1536-1539, 2003. [PubMed: 12743249, related citations] [Full Text]

  21. Klein, C., Brin, M. F., Kramer, P., Sena-Esteves, M., de Leon, D., Doheny, D., Bressman, S., Fahn, S., Breakefield, X. O., Ozelius, L. J. Association of a missense change in the D2 dopamine receptor with myoclonus dystonia. Proc. Nat. Acad. Sci. 96: 5173-5176, 1999. [PubMed: 10220438, images, related citations] [Full Text]

  22. Klein, C., Gurvich, N., Sena-Esteves, M., Bressman, S., Brin, M. F., Ebersole, B. J., Fink, S., Forsgren, L., Friedman, J., Grimes, D., Holmgren, G., Kyllerman, M., and 13 others. Evaluation of the role of the D2 dopamine receptor in myoclonus dystonia. Ann. Neurol. 47: 369-373, 2000. [PubMed: 10716258, related citations]

  23. Klein, C., Liu, L., Doheny, D., Kock, N., Muller, B., de Carvalho Aguiar, P., Leung, J., de Leon, D., Bressman, S. B., Silverman, J., Smith, C., and 9 others. Epsilon-sarcoglycan mutations found in combination with other dystonia gene mutations. Ann. Neurol. 52: 675-679, 2002. [PubMed: 12402271, related citations] [Full Text]

  24. Klein, C., Schilling, K., Saunders-Pullman, R. J., Garrels, J., Breakefield, X. O., Brin, M. F., deLeon, D., Doheny, D., Fahn, S., Fink, J. S., Forsgren, L., Friedman, J., and 20 others. A major locus for myoclonus-dystonia maps to chromosome 7q in eight families. Am. J. Hum. Genet. 67: 1314-1319, 2000. [PubMed: 11022010, images, related citations]

  25. Korten, J. J., Notermans, S. L. H., Frenken, C. W. G. M., Gabreels, F. J. M., Joosten, E. M. G. Familial essential myoclonus. Brain 97: 131-138, 1974. [PubMed: 4434166, related citations] [Full Text]

  26. Kurlan, R., Behr, J., Medved, L., Shoulson, I. Myoclonus and dystonia: a family study. Adv. Neurol. 50: 385-389, 1988. [PubMed: 3400497, related citations]

  27. Kyllerman, M., Forsgren, L., Sanner, G., Holmgren, G., Wahlstrom, J., Drugge, U. Alcohol-responsive myoclonic dystonia in a large family: dominant inheritance and phenotypic variation. Mov. Disord. 5: 270-279, 1990. [PubMed: 2259350, related citations] [Full Text]

  28. Lindermulder, F. G. Familial myoclonia occurring in three successive generations. J. Nerv. Ment. Dis. 77: 489-491, 1933.

  29. Littlejohn, W. S. Familial myoclonus: report of four cases with electroencephalograms. Sth. Med. J. 42: 404-410, 1949. [PubMed: 18118778, related citations]

  30. Mahloudji, M., Pikielny, R. T. Hereditary essential myoclonus. Brain 90: 669-674, 1967. [PubMed: 6058147, related citations] [Full Text]

  31. Muller, U., Kupke, K. G. The genetics of primary torsion dystonia. Hum. Genet. 84: 107-115, 1990. [PubMed: 2404852, related citations] [Full Text]

  32. Muller, U., Steinberger, D., Nemeth, A. H. Clinical and molecular genetics of primary dystonias. Neurogenetics 1: 165-177, 1998. [PubMed: 10737119, related citations] [Full Text]

  33. Nemeth, A. H. The genetics of primary dystonias and related disorders. Brain 125: 695-721, 2002. [PubMed: 11912106, related citations] [Full Text]

  34. Nygaard, T. G., Raymond, D., Chen, C., Nishino, I., Greene, P. E., Jennings, D., Heiman, G. A., Klein, C., Saunders-Pullman, R. J., Kramer, P., Ozelius, L. J., Bressman, S. B. Localization of a gene for myoclonus-dystonia to chromosome 7q21-q31. Ann. Neurol. 46: 794-798, 1999. [PubMed: 10554001, related citations] [Full Text]

  35. Orth, M., Djarmati, A., Baumer, T., Winkler, S., Grunewald, A., Lohmann-Hedrich, K., Kabakci, K., Hagenah, J., Klein, C., Munchau, A. Autosomal dominant myoclonus-dystonia and Tourette syndrome in a family without linkage to the SGCE gene. Mov. Disord. 22: 2090-2096, 2007. [PubMed: 17702041, related citations] [Full Text]

  36. Quinn, N. P., Rothwell, J. C., Thompson, P. D., Marsden, C. D. Hereditary myoclonic dystonia, hereditary torsion dystonia and hereditary essential myoclonus: an area of confusion. Adv. Neurol. 50: 391-400, 1988. [PubMed: 3400498, related citations]

  37. Roze, E., Apartis, E., Clot, F., Dorison, N., Thobois, S., Guyant-Marechal, L., Tranchant, C., Damier, P., Doummar, D., Bahi-Buisson, N., Andre-Obadia, N., Maltete, D., and 11 others. Myoclonus-dystonia: clinical and electrophysiologic pattern related to SGCE mutations. Neurology 70: 1010-1016, 2008. [PubMed: 18362280, related citations] [Full Text]

  38. Schule, B., Kock, N., Svetel, M., Dragasevic, N., Hedrich, K., de Carvalho Aguiar, P., Liu, L., Kabakci, K., Garrels, L., Meyer, E.-M., Berisavac, I, Schwinger, E., Kramer, P. L., Ozelius, L. J., Klein, C., Kostic, V. Genetic heterogeneity in ten families with myoclonus-dystonia. J. Neurol. Neurosurg. Psychiat. 75: 1181-1185, 2004. [PubMed: 15258227, related citations] [Full Text]

  39. Symonds, C. P. Nocturnal myoclonus. J. Neurol. Neurosurg. Psychiat. 16: 166-171, 1953. [PubMed: 13085198, related citations] [Full Text]

  40. Tezenas du Montcel, S., Clot, F., Vidailhet, M., Roze, E., Damier, P., Jedynak, C. P., Camuzat, A., Lagueny, A., Vercueil, L., Doummar, D., Guyant-Marechal, L., Houeto, J.-L., and 10 others. Epsilon sarcoglycan mutations and phenotype in French patients with myoclonic syndromes. J. Med. Genet. 43: 394-400, 2006. [PubMed: 16227522, related citations] [Full Text]

  41. Valente, E. M., Edwards, M. J., Mir, P., DiGiorgio, A., Salvi, S., Davis, M., Russo, N., Bozi, M., Kim, H.-T., Pennisi, G., Quinn, N., Dallapiccola, B., Bhatia, K. P. The epsilon-sarcoglycan gene in myoclonic syndromes. Neurology 64: 737-739, 2005. [PubMed: 15728306, related citations] [Full Text]

  42. Valente, E.-M., Misbahuddin, A., Brancati, F., Placzek, M. R., Garavaglia, B., Salvi, S., Nemeth, A., Shaw-Smith, C., Nardocci, N., Bentivoglio, A.-R., Berardelli, A., Eleopra, R., Dallapiccola, B., Warner, T. T. Analysis of the epsilon-sarcoglycan gene in familial and sporadic myoclonus-dystonia: evidence for genetic heterogeneity. Mov. Disord. 18: 1047-1051, 2003. [PubMed: 14502674, related citations] [Full Text]

  43. Vidailhet, M., Tassin, J., Durif, F., Nivelon-Chevallier, A., Agid, Y., Brice, A., Durr, A. A major locus for several phenotypes of myoclonus-dystonia on chromosome 7q. Neurology 56: 1213-1216, 2001. [PubMed: 11342690, related citations] [Full Text]

  44. Wahlstrom, J., Ozelius, L., Kramer, P., Kyllerman, M., Schuback, D., Forsgren, L., Holmgren, G., Drugge, U., Sanner, G., Fahn, S., Breakefield, X. O. The gene for familial dystonia with myoclonic jerks responsive to alcohol is not located on the distal end of 9q. Clin. Genet. 45: 88-92, 1994. [PubMed: 8004804, related citations] [Full Text]

  45. Zimprich, A., Grabowski, M., Asmus, F., Naumann, M., Berg, D., Bertram, M., Scheidtmann, K., Kern, P., Winkelmann, J., Muller-Myhsok, B., Riedel, L., Bauer, M., Muller, T., Castro, M., Meitinger, T., Strom, T. M., Gasser, T. Mutations in the gene encoding epsilon-sarcoglycan cause myoclonus-dystonia syndrome. Nature Genet. 29: 66-69, 2001. [PubMed: 11528394, related citations] [Full Text]


Cassandra L. Kniffin - updated : 3/5/2013
Cassandra L. Kniffin - updated : 5/5/2011
Cassandra L. Kniffin - updated : 5/1/2009
Cassandra L. Kniffin - updated : 3/23/2009
Cassandra L. Kniffin - updated : 1/5/2009
Cassandra L. Kniffin - updated : 2/5/2008
Cassandra L. Kniffin - updated : 8/29/2007
Cassandra L. Kniffin - updated : 6/25/2007
Cassandra L. Kniffin - updated : 6/12/2006
Cassandra L. Kniffin - updated : 3/3/2006
Cassandra L. Kniffin - updated : 6/9/2005
Marla J. F. O'Neill - updated : 5/12/2004
Cassandra L. Kniffin - updated : 8/12/2003
Cassandra L. Kniffin - updated : 8/8/2003
Cassandra L. Kniffin - updated : 12/26/2002
Cassandra L. Kniffin - updated : 12/4/2002
Cassandra L. Kniffin - updated : 6/17/2002
Cassandra L. Kniffin - updated : 6/3/2002
Victor A. McKusick - updated : 8/23/2001
Ada Hamosh - updated : 11/16/2000
Victor A. McKusick - updated : 2/18/2000
Victor A. McKusick - updated : 5/19/1998
Victor A. McKusick - updated : 5/5/1998
Iosif W. Lurie - updated : 8/10/1996
Creation Date:
Victor A. McKusick : 6/2/1986
carol : 01/09/2024
alopez : 03/17/2023
carol : 12/09/2020
carol : 06/04/2019
carol : 10/22/2015
alopez : 3/13/2013
ckniffin : 3/5/2013
wwang : 5/23/2011
ckniffin : 5/5/2011
wwang : 12/29/2010
terry : 12/16/2009
wwang : 8/5/2009
ckniffin : 5/27/2009
wwang : 5/8/2009
ckniffin : 5/1/2009
ckniffin : 4/30/2009
wwang : 4/7/2009
ckniffin : 3/23/2009
terry : 2/2/2009
wwang : 1/14/2009
ckniffin : 1/5/2009
wwang : 2/12/2008
ckniffin : 2/5/2008
wwang : 9/12/2007
ckniffin : 8/29/2007
wwang : 6/28/2007
ckniffin : 6/25/2007
wwang : 6/16/2006
ckniffin : 6/12/2006
wwang : 3/13/2006
ckniffin : 3/3/2006
wwang : 6/15/2005
wwang : 6/14/2005
ckniffin : 6/9/2005
carol : 5/13/2004
terry : 5/12/2004
ckniffin : 8/12/2003
tkritzer : 8/12/2003
ckniffin : 8/8/2003
carol : 1/17/2003
ckniffin : 1/16/2003
ckniffin : 1/16/2003
cwells : 1/7/2003
ckniffin : 12/27/2002
ckniffin : 12/26/2002
cwells : 12/10/2002
ckniffin : 12/4/2002
alopez : 8/19/2002
carol : 6/17/2002
ckniffin : 6/17/2002
carol : 6/17/2002
ckniffin : 6/4/2002
ckniffin : 6/3/2002
mcapotos : 12/19/2001
alopez : 9/19/2001
alopez : 9/19/2001
alopez : 9/18/2001
alopez : 8/27/2001
terry : 8/23/2001
carol : 11/27/2000
mgross : 11/17/2000
carol : 11/17/2000
mgross : 11/17/2000
terry : 11/16/2000
carol : 11/15/2000
carol : 11/15/2000
mgross : 3/16/2000
terry : 2/18/2000
carol : 2/9/1999
carol : 5/22/1998
terry : 5/19/1998
carol : 5/16/1998
terry : 5/5/1998
carol : 8/10/1996
mimadm : 12/2/1994
supermim : 3/16/1992
supermim : 4/15/1990
supermim : 3/23/1990
supermim : 3/20/1990
supermim : 2/28/1990

# 159900

DYSTONIA 11, MYOCLONIC; DYT11


Alternative titles; symbols

MYOCLONUS-DYSTONIA SYNDROME
MYOCLONIC DYSTONIA
DYSTONIA, ALCOHOL-RESPONSIVE
MYOCLONUS, HEREDITARY ESSENTIAL


SNOMEDCT: 439732004;   ORPHA: 36899;   DO: 0090034;  


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
7q21.3 Dystonia-11, myoclonic 159900 Autosomal dominant 3 SGCE 604149

TEXT

A number sign (#) is used with this entry because of evidence that myoclonic dystonia-11 (DYT11) is caused by heterozygous mutation in the epsilon-sarcoglycan gene (SGCE; 604149) on chromosome 7q21.


Description

Myoclonus-dystonia is a genetically heterogeneous disorder characterized by myoclonic jerks affecting mostly proximal muscles. Dystonia, usually torticollis or writer's cramp, is observed in most patients, but occasionally can be the only symptom of the disorder. Onset of the disorder is usually in the first or second decade. Symptoms often respond to alcohol, and patients may also have psychiatric abnormalities (Valente et al., 2003; Schule et al., 2004).


Clinical Features

Myoclonic dystonia, or myoclonus-dystonia, has dystonia as the core feature, but tremor or rapid jerky movements resembling myoclonus may also be present. The age of onset, pattern of body involvement, presence of myoclonus, and response to alcohol are all variable. Essential myoclonus is a relatively mild condition starting in the first or second decade, and is inherited as an autosomal dominant trait with incomplete penetrance. Some patients with essential myoclonus also have dystonia, but there are usually no other neurologic symptoms, and there may be a dramatic response to alcohol (Nemeth, 2002).

In a family of French Canadian background, a father and 5 of his 9 children showed onset of myoclonus in the first or second decade and a benign course without seizures, dementia, or neurologic signs other than myoclonus (Mahloudji and Pikielny, 1967). Because of the uncertainty of the nature of the case, on the basis of which Friedreich in 1881 introduced the term paramyoclonus multiplex, these cases might best be called hereditary essential myoclonus.

Daube and Peters (1966) reported 2 families with hereditary essential myoclonus in each of which affected members occurred in at least 4 generations, with male-to-male transmission but some skipped generations. Symonds (1953) described nocturnal myoclonus in a man and 5 of his 6 children. Muller and Kupke (1990) interpreted the family reported by Mahloudji and Pikielny (1967) as an instance of what they termed myoclonic dystonia, i.e., the association of torsion dystonia with myoclonus (muscle jerks). They pointed to families with the same disorder reported by Benedek and Rakonitz (1940), Quinn et al. (1988), and Kurlan et al. (1988).

Unlike other forms of dystonia (e.g., 128100), myoclonic dystonia may be highly responsive to ethanol ingestion and frequently also to clonazepam therapy and usually pursues a benign course. Kyllerman et al. (1990) described a 6-generation Swedish family with alcohol-responsive hereditary myoclonus. After clinical examination of 20 affected persons, myoclonus was found in the arms, shoulders, and neck of 17. The onset of myoclonus was between 2 and 3 years of age. The onset of leg dystonia was from 6 to 18 months of age.

Nygaard et al. (1999) reported a large American kindred of European and Native American ancestry with essential familial myoclonic dystonia that was responsive to alcohol. There were 10 definitely affected living individuals. Four had both myoclonus and dystonia, 5 had myoclonus alone, and 1 had brachial dystonia only. However, among the 5 judged to have only myoclonus, 4 had occasional sustained contractions and subtle posturing that might suggest mild dystonia. Mean age at onset of symptoms was 6.5 years (range, 4 to 15 years) in the 8 individuals able to recall onset. All affected individuals who tried alcohol reported relief of symptoms. Several family members had sought medical attention; levodopa was ineffective, and clonazepam or valproate gave mild benefit. Nine out of the 10 affected family members reported psychiatric problems, including diagnoses and treatment for depression, anxiety, and obsessive-compulsive disorder.

Asmus et al. (2002) reported 24 affected patients from 9 families, confirmed by genetic analysis of the SGCE gene (1 previously known and 6 novel heterozygous mutations were identified). The clinical presentation was homogeneous, with myoclonus affecting primarily the neck, trunk, and upper extremities at a mean age of onset of 5.4 years (range 0.5 to 20 years). Dystonia presented mostly in a focal distribution as cervical dystonia and/or writer's cramp at a mean age of onset of 8.8 years (range 1 to 38 years), often occurring in parallel with worsening of myoclonus. Myoclonus was improved by alcohol in 21 of 24 affected, and 5 affected members of 3 families had a history of panic attacks, depression, and agoraphobia. Pedigree analysis showed reduced penetrance of the phenotype upon maternal inheritance of the mutated allele, indicating genomic imprinting.

Doheny et al. (2002) described in detail the motor symptoms, psychiatric disorders, and neuropsychologic deficits in 3 families with myoclonus-dystonia syndrome who carried mutations in the SGCE gene. One family also carried a mutation in the DRD2 gene. Motor expression was variable, with onset of myoclonus or dystonia or both affecting the upper body and progression to myoclonus and dystonia in most cases. Psychiatric profiles revealed depression, obsessive-compulsive disorder, substance abuse, anxiety/panic/phobic disorders, and psychosis in 2 families, and depression only in the third family. Averaged scores from cognitive testing showed impaired verbal learning and memory in 1 family, impaired memory in the second family, and no cognitive deficits in the third family. Doheny et al. (2002) concluded that cognitive deficits may be associated with myoclonus-dystonia and that psychiatric abnormalities correlated with motor symptoms in affected individuals.

In a large family with myoclonus-dystonia syndrome and a mutation in the SGCE gene (604149.0008), Hjermind et al. (2003) reported prominent involvement of the legs, leading to disability in some, and laryngeal involvement causing vocal myoclonus.

Valente et al. (2005) identified SGCE mutations in 6 (21%) of 29 patients with essential myoclonus and myoclonic dystonia; no SGCE mutations were identified in another 29 patients with a broader myoclonus/dystonia phenotype. The patients with mutations typically had early onset of predominant myoclonus and milder dystonia, with an upper body predilection. Dystonia tended to have a later onset than that of myoclonus. Most patients' symptoms improved with alcohol. Autosomal dominant paternal inheritance was observed. Valente et al. (2005) noted the clinical phenotypic overlap of myoclonic dystonia, essential myoclonus, 'jerky' dystonia, Ramsay Hunt syndrome (213400), and benign hereditary chorea (118700).

Gerrits et al. (2006) reported 31 unrelated patients with a clinical diagnosis of myoclonus-dystonia, of whom 7 were found to have mutations in the SGCE gene. Clinical comparisons between mutation-positive and mutation-negative patients showed that the former had earlier disease onset before age 20 years. Mutation carriers first presented mostly with both myoclonus and dystonia, whereas mutation-negative patients usually presented with one or the other symptom. Those with mutations also tended to have a family history of the disorder, as well as truncal myoclonus and axial dystonia. There were no significant differences between the 2 groups regarding alcohol sensitivity or psychiatric symptoms.

Roze et al. (2008) reviewed the features of 41 patients from 22 French families with SGCE mutation-positive myoclonus dystonia. The mean age at onset was 6 years (range, 1 to 18 years). Myoclonus was the presenting feature in 29 patients, 5 of whom also presented with dystonia. Ten patients presented with isolated dystonia, and 2 patients from the same family presented with hypotonia. Dystonia was axial, mostly cervical, in 13 patients, in the upper limbs in 18 patients, and in the lower limbs in 9 patients. One patient had laryngeal dystonia. Myoclonus involved the axis in 90% of cases, most commonly with cervical and upper limb involvement. Myoclonus of the face and voice occurred in 27% and 24%, respectively, and involved the lower limbs in 34% of patients. Myoclonus was present at rest in 70% of patients, and increased with posture and action in 95%. Neurophysiologic studies showed that myoclonus could be synchronous or asynchronous, isolated, and mostly arrhythmic. The studies indicated a subcortical origin: myoclonus was stimulus insensitive; the mean duration of myoclonus was 95 seconds, which is longer than that observed in cortical myoclonus; and there were no features of cortical hyperexcitability, as reflected by a negative C-reflex response. Nine patients had spontaneous remission of the dystonia during childhood or adolescence. Eight patients had associated psychiatric disturbances, including obsessive-compulsive disorder, severe anxiety and depression, attention-deficit hyperactivity disorder, and phobic disorder. There were no clear genotype/phenotype correlations.


Other Features

Hess et al. (2007) studied psychiatric manifestations in 5 unrelated families with myoclonus-dystonia confirmed by genetic analysis. Among a total of 64 family members, manifesting SGCE mutation carriers showed increased alcohol dependence compared to nonmanifesting carriers and controls (35% and 11.4%, respectively), but the association was not significant for the mutation carrier group overall. There was an increase in the rate of obsessive-compulsive disorder (OCD) in mutation carriers compared to non-carriers (16.7% and 3.0%, respectively), but it did not reach significance. However, there was no case of OCD among 10 nonmanifesting carriers, and only 1 noncarrier fit OCD criteria. In patients with OCD, the onset of motor symptoms preceded OCD by about 10 years. Hess et al. (2007) concluded that alcohol dependence in myoclonus-dystonia patients is related to self-medication to improve motor symptoms, whereas OCD may be a manifestation of mutant gene expression triggered after the onset of movement symptoms.


Clinical Management

Azoulay-Zyss et al. (2011) reported favorable results in 5 patients with severe and refractory myoclonus-dystonia treated with bilateral deep brain stimulation of the internal pallidum. All patients showed significant functional improvement and improvement on measurable scoring systems at 6 to 9 months after surgery. The median improvement in score was an 85% decrease for dystonia and an 83% decrease for myoclonus. After 15 to 18 months, 3 patients were medication-free, 1 of whom received botulism injections for mild cervical dystonia. The other 2 patients were on low doses of benzodiazepines. There were no adverse effects.

Contarino et al. (2011) reported a significantly favorable motor response in 5 patients with myoclonus-dystonia after deep brain stimulation of the internal pallidum. However, 4 of 5 patients had worsening of preexisting psychiatric disorders after the treatment despite the improvement of the motor disabilities. One patient had no change in the psychiatric comorbidity. Preoperative psychiatric symptoms were present in all 5 patients, and mainly included depressive episodes and social anxiety disorder, but were untreated and not considered severe enough to contraindicate surgery. Contarino et al. (2011) concluded that psychiatric comorbidity may be intrinsic to the disorder or secondary to the movement disorder, but that worsening could not be definitively linked to the treatment. They recommended that pre- and postoperative psychiatric evaluation needs to be considered in all patients with this disorder. Grabli et al. (2011) noted that of the 5 patients in their study (Azoulay-Zyss et al., 2011), all had mild generalized anxiety and 1 had a major depressive episode before the treatment. No clinically meaningful psychiatric adverse effect was identified during 18-month follow-up of these patients, and some patients reported improvement in their anxiety. The discrepancy in the outcome between the 2 studies could not be explained.


Mapping

In the Swedish family reported by Kyllerman et al. (1990), Wahlstrom et al. (1994) excluded linkage of the gene responsible for this disorder to 9q32-q34, where the DYT1 gene (TOR1A; 605204) for susceptibility to early-onset torsion dystonia (128100) was mapped, suggesting another locus was responsible. In a large German kindred with alcohol-responsive myoclonic dystonia, Gasser et al. (1996) also excluded linkage to the 9q34 region.

Linkage to Chromosome 7q21

Zimprich et al. (2001) performed pedigree analysis on all families with myoclonus-dystonia syndrome who had known mutations in SGCE (604149) and/or linkage to chromosome 7q21 (DYT11). The high level of dependence of penetrance on the parental origin of the disease allele was demonstrated. Of 62 clinically affected individuals (40 males and 22 females), 49 inherited the disease from their father and only 4 from their mother. In 9 cases, parental origin could not be determined. In contrast, they found a maternal origin of the affected allele in 14 of 18 clinically asymptomatic carriers (12 males and 6 females, carrier status being determined either by sequencing or by pedigree position), whereas paternal transmission occurred in only 3. In one case, parental origin could not be determined.

Nygaard et al. (1999) mapped the locus for myoclonic dystonia in the large American kindred of European and Native American ancestry studied by them to a 28-cM interval spanning the markers D7S802 and D7S1799 in 7q21-q31. The highest pairwise lod score was 3.91 at theta of 0.0 at both D7S657 and D7S796.

Klein et al. (2000) performed genetic studies in 8 families with myoclonic dystonia. In all 8 families, they found linkage to chromosome 7 markers, with a combined multipoint lod score of 11.71. Recombination events in the families placed the disease gene within a 14-cM interval flanked by D7S2212 and D7S821. These data provided evidence for a major locus for myoclonic dystonia on 7q21.

Asmus et al. (2001) narrowed the 7q21-q31 locus for the myoclonus-dystonia syndrome in German families.

Vidailhet et al. (2001) performed linkage analysis in 3 families with myoclonic dystonia and 1 family with essential myoclonus, and found positive lod scores for 6 markers on 7q21-q31 in all families. Linkage to the DRD2 locus was excluded in all families. Although there was wide clinical variation both between and within families in age of onset, involvement of limbs, trunk, or neck, and responsiveness to alcohol, the authors suggested that different phenotypes may be due to allelic mutations in a single gene.


Heterogeneity

Valente et al. (2003) excluded mutations in the SGCE gene in 16 patients with myoclonus dystonia, indicating genetic heterogeneity. Three patients had a family history consistent with autosomal dominant inheritance. Schule et al. (2004) also excluded SGCE mutation in 5 of 7 families with autosomal dominant myoclonus dystonia, again indicating genetic heterogeneity.

Orth et al. (2007) reported a 3-generation family with both myoclonus dystonia and Gilles de la Tourette syndrome (GTS; 137580). There were 11 affected individuals: 3 had myoclonus dystonia, 2 had dystonia, 1 had GTS, 1 had tics, and 4 had various combinations of these with obsessive compulsive disorder. The phenotype of those with myoclonus dystonia was similar to that described for most families, with predominantly head, neck and arm myoclonus, mild cervical dystonia, and writer's cramp. Linkage analysis excluded association to the SGCE, DYT15 (607488), DYT1, or DRD2 (126450) loci, and no pathogenic changes were identified in the SLITRK1 gene (609678). Orth et al. (2007) suggested that there may be a novel susceptibility gene for both myoclonus dystonia and Tourette syndrome.


Inheritance

The transmission pattern of myoclonic dystonia in the families reported by Zimprich et al. (2001) was consistent with autosomal dominant inheritance.


Molecular Genetics

Using a positional cloning approach, Zimprich et al. (2001) identified 5 different heterozygous loss-of-function mutations in the SGCE gene (604149.0001-604149.0005) in patients with myoclonus-dystonia syndrome. SGCE was found to be expressed in all brain regions examined. Pedigree analysis showed a marked difference in penetrance depending on the parental origin of the disease allele. This was indicative of a maternal imprinting mechanism, which had been demonstrated in the case of the mouse epsilon-sarcoglycan gene.

Using bisulfite genomic sequencing to study methylation patterns of the SGCE gene in samples from patients with myoclonus-dystonia syndrome, Grabowski et al. (2003) found strong evidence for maternal imprinting of the SGCE gene.

In a Dutch family with myoclonus-dystonia syndrome spanning 5 generations, previously reported by Doheny et al. (2002), Foncke et al. (2003) identified a mutation in the SGCE gene (604149.0007). In addition to the typical motor symptoms, 3 of 5 living affected members also had EEG abnormalities and seizures. Seizures consisted of episodes of reduced consciousness and staring, amnesia, and panic-like feelings, suggestive of temporal-limbic origin. Foncke et al. (2003) suggested that epilepsy should not be considered an exclusion criterion for the clinical diagnosis of myoclonus-dystonia syndrome.

Asmus et al. (2005) identified 2 different large heterozygous deletions in the SGCE gene (604149.0010 and 604149.0011) in affected members from 2 unrelated families with myoclonic dystonia. The deletion was paternally inherited in all cases with motor symptoms. In 1 family, a man who inherited the mutation maternally did not have motor symptoms but did have alcohol dependence.

Tezenas du Montcel et al. (2006) identified 13 different mutations in the SGCE gene in 16 of 76 unrelated French Caucasian patients with myoclonus-dystonia or essential myoclonus. In 12 families (75%), at least 1 other family member was affected. Penetrance was complete in paternal transmissions and null in maternal transmissions. None of the patients had severe psychiatric disorders.

In affected members of a large Dutch family with myoclonus-dystonia syndrome reported by Korten et al. (1974), Foncke et al. (2006) identified a heterozygous mutation in the SGCE gene (604149.0012). The mutation was identified in all 19 symptomatic relatives, all 5 'possibly affected' relatives, and in 9 clinically unaffected relatives. All symptomatic individuals inherited the mutation from their father, and all asymptomatic individuals inherited it from their mother. Foncke et al. (2006) noted that subtle distal myoclonus of the fingers was a prominent feature in this family.

Associations Pending Confirmation

In a family containing 8 members with myoclonic dystonia, Klein et al. (1999) found heterozygosity for a variation in the DRD2 gene (V154I; 126450.0001); however, Klein et al. (2002) later identified a 5-bp deletion in the SGCE gene (604149.0005) in all 8 affected members. There were 2 unaffected carriers of both mutations. The contribution of each mutation to the clinical phenotype could not be determined, but the phenotype most likely resulted from the SGCE mutation, as Klein et al. (2000) showed that the V154I DRD2 mutant protein was similar to wildtype and did not show impaired activity in in vitro studies. (See also Furukawa and Rajput, 2002).

By direct sequencing, Klein et al. (2000) excluded DRD2 mutations in 5 unrelated probands with myoclonus dystonia. Four additional families were excluded by linkage analysis. Durr et al. (2000) excluded mutations in the DRD2 gene in 9 unrelated families with myoclonic dystonia or essential myoclonus and variable responses to alcohol. The authors concluded that DRD2 mutations are rare in these disorders.

For discussion of a possible association between myoclonic dystonia and variation in the DYT1 (TOR1A) gene, see 605204.0002.


Cytogenetics

Guettard et al. (2008) reported a 35-year-old man with myoclonus-dystonia and Silver-Russell syndrome (SRS; 180860). Cytogenetic analysis identified mosaicism for a small supernumerary ring chromosome derived from the pericentric region of chromosome 7, which was considered unlikely to contribute to the phenotype as it contained only the EGFR gene (131550). Microsatellite analysis indicated loss of the paternal allele and maternal uniparental disomy of chromosome 7 (UPD7) that was maternally imprinted with loss of SGCE expression. There were no mutations in the SGCE gene. The findings indicated that UPD7 resulted in repression of both alleles of the maternally imprinted SGCE gene, suggesting loss of function of SGCE as the disease mechanism.


See Also:

Biemond (1963); Lindermulder (1933); Littlejohn (1949); Muller et al. (1998)

REFERENCES

  1. Asmus, F., Salih, F., Hjermind, L. E., Ostergaard, K., Munz, M., Kuhn, A. A., Dupont, E., Kupsch, A., Gasser, T. Myoclonus-dystonia due to genomic deletions in the epsilon-sarcoglycan gene. Ann. Neurol. 58: 792-797, 2005. [PubMed: 16240355] [Full Text: https://doi.org/10.1002/ana.20661]

  2. Asmus, F., Zimprich, A., Naumann, M., Berg, D., Bertram, M., Ceballos-Baumann, A., Pruszak-Seel, R., Kabus, C., Dichgans, M., Fuchs, S., Muller-Myhsok, B., Gasser, T. Inherited myoclonus-dystonia syndrome: narrowing the 7q21-q31 locus in German families. Ann. Neurol. 49: 121-124, 2001. [PubMed: 11198282] [Full Text: https://doi.org/10.1002/1531-8249(200101)49:1<121::aid-ana20>3.0.co;2-8]

  3. Asmus, F., Zimprich, A., Tezenas du Montcel, S., Kabus, C., Deuschl, G., Kupsch, A., Ziemann, U., Castro, M., Kuhn, A. A., Strom, T. M., Vidailhet, M., Bhatia, K. P., Durr, A., Wood, N. W., Brice, A., Gasser, T. Myoclonus-dystonia syndrome: epsilon-sarcoglycan mutations and phenotype. Ann. Neurol. 52: 489-492, 2002. [PubMed: 12325078] [Full Text: https://doi.org/10.1002/ana.10325]

  4. Azoulay-Zyss, J., Roze, E., Welter, M.-L., Navarro, S., Yelnik, J., Clot, F., Bardinet, E., Karachi, C., Dormont, D., Galanaud, D., Pidoux, B., Cornu, P., Vidailhet, M., Grabli, D. Bilateral deep brain stimulation of the pallidum for myoclonus-dystonia due to epsilon-sarcoglycan mutations: a pilot study. Arch. Neurol. 68: 94-98, 2011. [PubMed: 21220679] [Full Text: https://doi.org/10.1001/archneurol.2010.338]

  5. Benedek, L., Rakonitz, E. Heredopathic combination of a congenital deformity of the nose and of myoclonic torsion dystonia. J. Nerv. Ment. Dis. 91: 606-616, 1940.

  6. Biemond, A. Paramyoclonus multiplex (Friedreich). Clinical and genetic aspects. Psychiat. Neurol. Neurochir. 66: 270-276, 1963. [PubMed: 14062193]

  7. Contarino, M. F, Foncke, E. M., Cath, D. C., Schuurman, P. R., Speelman, J. D., Tijssen, M. A. J. Effect of pallidal deep brain stimulation on psychiatric symptoms in myoclonus-dystonia due to epsilon-sarcoglycan mutations. (Letter) Arch. Neurol. 68: 1087-1088, 2011. [PubMed: 21825253] [Full Text: https://doi.org/10.1001/archneurol.2011.180]

  8. Daube, J. R., Peters, H. A. Hereditary essential myoclonus. Arch. Neurol. 15: 587-594, 1966. [PubMed: 5925999] [Full Text: https://doi.org/10.1001/archneur.1966.00470180027003]

  9. Doheny, D. O., Brin, M. F., Morrison, C. E., Smith, C. J., Walker, R. H., Abbasi, S., Muller, B., Garrels, J., Liu, L., de Carvalho Aguiar, P., Schilling, K., Kramer, P., and 9 others. Phenotypic features of myoclonus-dystonia in three kindreds. Neurology 59: 1187-1196, 2002. [PubMed: 12391346] [Full Text: https://doi.org/10.1212/wnl.59.8.1187]

  10. Durr, A., Tassin, J., Vidailhet, M., Durif, F., Jedynak, P., Agid, Y., Brice, A. D2 dopamine receptor gene in myoclonic dystonia and essential myoclonus. Ann. Neurol. 48: 127-128, 2000. [PubMed: 10894231] [Full Text: https://doi.org/10.1002/1531-8249(200007)48:1<127::aid-ana24>3.3.co;2-4]

  11. Foncke, E. M. J., Gerrits, M. C. F., van Ruissen, F., Baas, F., Hedrich, K., Tijssen, C. C., Klein, C., Tijssen, M. A. J. Distal myoclonus and late onset in a large Dutch family with myoclonus-dystonia. Neurology 67: 1677-1680, 2006. [PubMed: 17101905] [Full Text: https://doi.org/10.1212/01.wnl.0000242880.49051.1f]

  12. Foncke, E. M. J., Klein, C., Koelman, J. H. T. M., Kramer, P. L., Schilling, K., Muller, B., Garrels, J., de Carvalho Aguiar, P., Liu, L., de Froe, A., Speelman, J. D., Ozelius, L. J., Tijssen, M. A. J. Hereditary myoclonus-dystonia associated with epilepsy. Neurology 60: 1988-1990, 2003. [PubMed: 12821748] [Full Text: https://doi.org/10.1212/01.wnl.0000066020.99191.76]

  13. Furukawa, Y., Rajput, A. H. Inherited myoclonus-dystonia: how many causative genes and clinical phenotypes? Neurology 59: 1130-1131, 2002. [PubMed: 12391338] [Full Text: https://doi.org/10.1212/wnl.59.8.1130]

  14. Gasser, T., Bereznai, B., Muller, B., Pruszak-Seel, R., Damrich, R., Deuschl, G., Oertel, W. H. Linkage studies in alcohol-responsive myoclonic dystonia. Mov. Disord. 11: 363-370, 1996. [PubMed: 8813214] [Full Text: https://doi.org/10.1002/mds.870110403]

  15. Gerrits, M. C. F., Foncke, E. M. J., de Haan, R., Hedrich, K., van de Leemput, Y. L. C., Baas, F., Ozelius, L. J., Speelman, J. D., Klein, C., Tijssen, M. A. J. Phenotype-genotype correlation in Dutch patients with myoclonus-dystonia. Neurology 66: 759-761, 2006. Note: Erratum: Neurology 68: 879 only, 2007. [PubMed: 16534121] [Full Text: https://doi.org/10.1212/01.wnl.0000201192.66467.a3]

  16. Grabli, D., Roze, E., Azoulay-Zyss, J., Vidailhet, M. Reply to Contarino et al. Arch. Neurol. 68: 1088 only, 2011.

  17. Grabowski, M., Zimprich, A., Lorenz-Depiereux, B., Kalscheuer, V., Asmus, F., Gasser, T., Meitinger, T., Strom, T. M. The epsilon-sarcoglycan gene (SGCE), mutated in myoclonus-dystonia syndrome, is maternally imprinted. Europ. J. Hum. Genet. 11: 138-144, 2003. [PubMed: 12634861] [Full Text: https://doi.org/10.1038/sj.ejhg.5200938]

  18. Guettard, E., Portnoi, M.-F., Lohmann-Hedrich, K., Keren, B., Rossignol, S., Winkler, S., El Kamel, I., Leu, S., Apartis, E., Vidailhet, M., Klein, C., Roze, E. Myoclonus-dystonia due to maternal uniparental disomy. Arch. Neurol. 65: 1380-1385, 2008. [PubMed: 18852357] [Full Text: https://doi.org/10.1001/archneur.65.10.1380]

  19. Hess, C. W., Raymond, D., de Varvalho Aguiar, P., Frucht, S., Shriberg, J., Heiman, G. A., Kurlan, R., Klein, C., Bressman, S. B., Ozelius, L. J., Saunders-Pullman, R. Myoclonus-dystonia, obsessive-compulsive disorder, and alcohol dependence in SGCE mutation carriers. Neurology 68: 522-524, 2007. [PubMed: 17296918] [Full Text: https://doi.org/10.1212/01.wnl.0000253188.76092.06]

  20. Hjermind, L. E., Werdelin, L. M., Eiberg, H., Krag-Olsen, B., Dupont, E., Sorensen, S. A. A novel mutation in the epsilon-sarcoglycan gene causing myoclonus-dystonia syndrome. Neurology 60: 1536-1539, 2003. [PubMed: 12743249] [Full Text: https://doi.org/10.1212/01.wnl.0000061480.86610.bf]

  21. Klein, C., Brin, M. F., Kramer, P., Sena-Esteves, M., de Leon, D., Doheny, D., Bressman, S., Fahn, S., Breakefield, X. O., Ozelius, L. J. Association of a missense change in the D2 dopamine receptor with myoclonus dystonia. Proc. Nat. Acad. Sci. 96: 5173-5176, 1999. [PubMed: 10220438] [Full Text: https://doi.org/10.1073/pnas.96.9.5173]

  22. Klein, C., Gurvich, N., Sena-Esteves, M., Bressman, S., Brin, M. F., Ebersole, B. J., Fink, S., Forsgren, L., Friedman, J., Grimes, D., Holmgren, G., Kyllerman, M., and 13 others. Evaluation of the role of the D2 dopamine receptor in myoclonus dystonia. Ann. Neurol. 47: 369-373, 2000. [PubMed: 10716258]

  23. Klein, C., Liu, L., Doheny, D., Kock, N., Muller, B., de Carvalho Aguiar, P., Leung, J., de Leon, D., Bressman, S. B., Silverman, J., Smith, C., and 9 others. Epsilon-sarcoglycan mutations found in combination with other dystonia gene mutations. Ann. Neurol. 52: 675-679, 2002. [PubMed: 12402271] [Full Text: https://doi.org/10.1002/ana.10358]

  24. Klein, C., Schilling, K., Saunders-Pullman, R. J., Garrels, J., Breakefield, X. O., Brin, M. F., deLeon, D., Doheny, D., Fahn, S., Fink, J. S., Forsgren, L., Friedman, J., and 20 others. A major locus for myoclonus-dystonia maps to chromosome 7q in eight families. Am. J. Hum. Genet. 67: 1314-1319, 2000. [PubMed: 11022010]

  25. Korten, J. J., Notermans, S. L. H., Frenken, C. W. G. M., Gabreels, F. J. M., Joosten, E. M. G. Familial essential myoclonus. Brain 97: 131-138, 1974. [PubMed: 4434166] [Full Text: https://doi.org/10.1093/brain/97.1.131]

  26. Kurlan, R., Behr, J., Medved, L., Shoulson, I. Myoclonus and dystonia: a family study. Adv. Neurol. 50: 385-389, 1988. [PubMed: 3400497]

  27. Kyllerman, M., Forsgren, L., Sanner, G., Holmgren, G., Wahlstrom, J., Drugge, U. Alcohol-responsive myoclonic dystonia in a large family: dominant inheritance and phenotypic variation. Mov. Disord. 5: 270-279, 1990. [PubMed: 2259350] [Full Text: https://doi.org/10.1002/mds.870050403]

  28. Lindermulder, F. G. Familial myoclonia occurring in three successive generations. J. Nerv. Ment. Dis. 77: 489-491, 1933.

  29. Littlejohn, W. S. Familial myoclonus: report of four cases with electroencephalograms. Sth. Med. J. 42: 404-410, 1949. [PubMed: 18118778]

  30. Mahloudji, M., Pikielny, R. T. Hereditary essential myoclonus. Brain 90: 669-674, 1967. [PubMed: 6058147] [Full Text: https://doi.org/10.1093/brain/90.3.669]

  31. Muller, U., Kupke, K. G. The genetics of primary torsion dystonia. Hum. Genet. 84: 107-115, 1990. [PubMed: 2404852] [Full Text: https://doi.org/10.1007/BF00208922]

  32. Muller, U., Steinberger, D., Nemeth, A. H. Clinical and molecular genetics of primary dystonias. Neurogenetics 1: 165-177, 1998. [PubMed: 10737119] [Full Text: https://doi.org/10.1007/s100480050025]

  33. Nemeth, A. H. The genetics of primary dystonias and related disorders. Brain 125: 695-721, 2002. [PubMed: 11912106] [Full Text: https://doi.org/10.1093/brain/awf090]

  34. Nygaard, T. G., Raymond, D., Chen, C., Nishino, I., Greene, P. E., Jennings, D., Heiman, G. A., Klein, C., Saunders-Pullman, R. J., Kramer, P., Ozelius, L. J., Bressman, S. B. Localization of a gene for myoclonus-dystonia to chromosome 7q21-q31. Ann. Neurol. 46: 794-798, 1999. [PubMed: 10554001] [Full Text: https://doi.org/10.1002/1531-8249(199911)46:5<794::aid-ana19>3.0.co;2-2]

  35. Orth, M., Djarmati, A., Baumer, T., Winkler, S., Grunewald, A., Lohmann-Hedrich, K., Kabakci, K., Hagenah, J., Klein, C., Munchau, A. Autosomal dominant myoclonus-dystonia and Tourette syndrome in a family without linkage to the SGCE gene. Mov. Disord. 22: 2090-2096, 2007. [PubMed: 17702041] [Full Text: https://doi.org/10.1002/mds.21674]

  36. Quinn, N. P., Rothwell, J. C., Thompson, P. D., Marsden, C. D. Hereditary myoclonic dystonia, hereditary torsion dystonia and hereditary essential myoclonus: an area of confusion. Adv. Neurol. 50: 391-400, 1988. [PubMed: 3400498]

  37. Roze, E., Apartis, E., Clot, F., Dorison, N., Thobois, S., Guyant-Marechal, L., Tranchant, C., Damier, P., Doummar, D., Bahi-Buisson, N., Andre-Obadia, N., Maltete, D., and 11 others. Myoclonus-dystonia: clinical and electrophysiologic pattern related to SGCE mutations. Neurology 70: 1010-1016, 2008. [PubMed: 18362280] [Full Text: https://doi.org/10.1212/01.wnl.0000297516.98574.c0]

  38. Schule, B., Kock, N., Svetel, M., Dragasevic, N., Hedrich, K., de Carvalho Aguiar, P., Liu, L., Kabakci, K., Garrels, L., Meyer, E.-M., Berisavac, I, Schwinger, E., Kramer, P. L., Ozelius, L. J., Klein, C., Kostic, V. Genetic heterogeneity in ten families with myoclonus-dystonia. J. Neurol. Neurosurg. Psychiat. 75: 1181-1185, 2004. [PubMed: 15258227] [Full Text: https://doi.org/10.1136/jnnp.2003.027177]

  39. Symonds, C. P. Nocturnal myoclonus. J. Neurol. Neurosurg. Psychiat. 16: 166-171, 1953. [PubMed: 13085198] [Full Text: https://doi.org/10.1136/jnnp.16.3.166]

  40. Tezenas du Montcel, S., Clot, F., Vidailhet, M., Roze, E., Damier, P., Jedynak, C. P., Camuzat, A., Lagueny, A., Vercueil, L., Doummar, D., Guyant-Marechal, L., Houeto, J.-L., and 10 others. Epsilon sarcoglycan mutations and phenotype in French patients with myoclonic syndromes. J. Med. Genet. 43: 394-400, 2006. [PubMed: 16227522] [Full Text: https://doi.org/10.1136/jmg.2005.036780]

  41. Valente, E. M., Edwards, M. J., Mir, P., DiGiorgio, A., Salvi, S., Davis, M., Russo, N., Bozi, M., Kim, H.-T., Pennisi, G., Quinn, N., Dallapiccola, B., Bhatia, K. P. The epsilon-sarcoglycan gene in myoclonic syndromes. Neurology 64: 737-739, 2005. [PubMed: 15728306] [Full Text: https://doi.org/10.1212/01.WNL.0000151979.68010.9B]

  42. Valente, E.-M., Misbahuddin, A., Brancati, F., Placzek, M. R., Garavaglia, B., Salvi, S., Nemeth, A., Shaw-Smith, C., Nardocci, N., Bentivoglio, A.-R., Berardelli, A., Eleopra, R., Dallapiccola, B., Warner, T. T. Analysis of the epsilon-sarcoglycan gene in familial and sporadic myoclonus-dystonia: evidence for genetic heterogeneity. Mov. Disord. 18: 1047-1051, 2003. [PubMed: 14502674] [Full Text: https://doi.org/10.1002/mds.10476]

  43. Vidailhet, M., Tassin, J., Durif, F., Nivelon-Chevallier, A., Agid, Y., Brice, A., Durr, A. A major locus for several phenotypes of myoclonus-dystonia on chromosome 7q. Neurology 56: 1213-1216, 2001. [PubMed: 11342690] [Full Text: https://doi.org/10.1212/wnl.56.9.1213]

  44. Wahlstrom, J., Ozelius, L., Kramer, P., Kyllerman, M., Schuback, D., Forsgren, L., Holmgren, G., Drugge, U., Sanner, G., Fahn, S., Breakefield, X. O. The gene for familial dystonia with myoclonic jerks responsive to alcohol is not located on the distal end of 9q. Clin. Genet. 45: 88-92, 1994. [PubMed: 8004804] [Full Text: https://doi.org/10.1111/j.1399-0004.1994.tb04000.x]

  45. Zimprich, A., Grabowski, M., Asmus, F., Naumann, M., Berg, D., Bertram, M., Scheidtmann, K., Kern, P., Winkelmann, J., Muller-Myhsok, B., Riedel, L., Bauer, M., Muller, T., Castro, M., Meitinger, T., Strom, T. M., Gasser, T. Mutations in the gene encoding epsilon-sarcoglycan cause myoclonus-dystonia syndrome. Nature Genet. 29: 66-69, 2001. [PubMed: 11528394] [Full Text: https://doi.org/10.1038/ng709]


Contributors:
Cassandra L. Kniffin - updated : 3/5/2013
Cassandra L. Kniffin - updated : 5/5/2011
Cassandra L. Kniffin - updated : 5/1/2009
Cassandra L. Kniffin - updated : 3/23/2009
Cassandra L. Kniffin - updated : 1/5/2009
Cassandra L. Kniffin - updated : 2/5/2008
Cassandra L. Kniffin - updated : 8/29/2007
Cassandra L. Kniffin - updated : 6/25/2007
Cassandra L. Kniffin - updated : 6/12/2006
Cassandra L. Kniffin - updated : 3/3/2006
Cassandra L. Kniffin - updated : 6/9/2005
Marla J. F. O'Neill - updated : 5/12/2004
Cassandra L. Kniffin - updated : 8/12/2003
Cassandra L. Kniffin - updated : 8/8/2003
Cassandra L. Kniffin - updated : 12/26/2002
Cassandra L. Kniffin - updated : 12/4/2002
Cassandra L. Kniffin - updated : 6/17/2002
Cassandra L. Kniffin - updated : 6/3/2002
Victor A. McKusick - updated : 8/23/2001
Ada Hamosh - updated : 11/16/2000
Victor A. McKusick - updated : 2/18/2000
Victor A. McKusick - updated : 5/19/1998
Victor A. McKusick - updated : 5/5/1998
Iosif W. Lurie - updated : 8/10/1996

Creation Date:
Victor A. McKusick : 6/2/1986

Edit History:
carol : 01/09/2024
alopez : 03/17/2023
carol : 12/09/2020
carol : 06/04/2019
carol : 10/22/2015
alopez : 3/13/2013
ckniffin : 3/5/2013
wwang : 5/23/2011
ckniffin : 5/5/2011
wwang : 12/29/2010
terry : 12/16/2009
wwang : 8/5/2009
ckniffin : 5/27/2009
wwang : 5/8/2009
ckniffin : 5/1/2009
ckniffin : 4/30/2009
wwang : 4/7/2009
ckniffin : 3/23/2009
terry : 2/2/2009
wwang : 1/14/2009
ckniffin : 1/5/2009
wwang : 2/12/2008
ckniffin : 2/5/2008
wwang : 9/12/2007
ckniffin : 8/29/2007
wwang : 6/28/2007
ckniffin : 6/25/2007
wwang : 6/16/2006
ckniffin : 6/12/2006
wwang : 3/13/2006
ckniffin : 3/3/2006
wwang : 6/15/2005
wwang : 6/14/2005
ckniffin : 6/9/2005
carol : 5/13/2004
terry : 5/12/2004
ckniffin : 8/12/2003
tkritzer : 8/12/2003
ckniffin : 8/8/2003
carol : 1/17/2003
ckniffin : 1/16/2003
ckniffin : 1/16/2003
cwells : 1/7/2003
ckniffin : 12/27/2002
ckniffin : 12/26/2002
cwells : 12/10/2002
ckniffin : 12/4/2002
alopez : 8/19/2002
carol : 6/17/2002
ckniffin : 6/17/2002
carol : 6/17/2002
ckniffin : 6/4/2002
ckniffin : 6/3/2002
mcapotos : 12/19/2001
alopez : 9/19/2001
alopez : 9/19/2001
alopez : 9/18/2001
alopez : 8/27/2001
terry : 8/23/2001
carol : 11/27/2000
mgross : 11/17/2000
carol : 11/17/2000
mgross : 11/17/2000
terry : 11/16/2000
carol : 11/15/2000
carol : 11/15/2000
mgross : 3/16/2000
terry : 2/18/2000
carol : 2/9/1999
carol : 5/22/1998
terry : 5/19/1998
carol : 5/16/1998
terry : 5/5/1998
carol : 8/10/1996
mimadm : 12/2/1994
supermim : 3/16/1992
supermim : 4/15/1990
supermim : 3/23/1990
supermim : 3/20/1990
supermim : 2/28/1990